IBDEI0A0 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10015,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,10015,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,10015,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,10016,0)
 ;;=E11.39^^51^587^15
 ;;^UTILITY(U,$J,358.3,10016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10016,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complications
 ;;^UTILITY(U,$J,358.3,10016,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,10016,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,10017,0)
 ;;=E11.36^^51^587^14
 ;;^UTILITY(U,$J,358.3,10017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10017,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,10017,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,10017,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,10018,0)
 ;;=E11.359^^51^587^20
 ;;^UTILITY(U,$J,358.3,10018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10018,1,3,0)
 ;;=3^DM Type 2 w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10018,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,10018,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,10019,0)
 ;;=E11.351^^51^587^21
 ;;^UTILITY(U,$J,358.3,10019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10019,1,3,0)
 ;;=3^DM Type 2 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10019,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,10019,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,10020,0)
 ;;=E11.349^^51^587^22
 ;;^UTILITY(U,$J,358.3,10020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10020,1,3,0)
 ;;=3^DM Type 2 w/ Severe NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10020,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,10020,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,10021,0)
 ;;=E11.341^^51^587^23
 ;;^UTILITY(U,$J,358.3,10021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10021,1,3,0)
 ;;=3^DM Type 2 w/ Severe NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10021,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,10021,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,10022,0)
 ;;=E11.339^^51^587^18
 ;;^UTILITY(U,$J,358.3,10022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10022,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10022,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,10022,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,10023,0)
 ;;=E11.331^^51^587^19
 ;;^UTILITY(U,$J,358.3,10023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10023,1,3,0)
 ;;=3^DM Type 2 w/ Moderate NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10023,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,10023,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,10024,0)
 ;;=E11.329^^51^587^16
 ;;^UTILITY(U,$J,358.3,10024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10024,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10024,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,10024,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,10025,0)
 ;;=E11.321^^51^587^17
 ;;^UTILITY(U,$J,358.3,10025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10025,1,3,0)
 ;;=3^DM Type 2 w/ Mild NonProlif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10025,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,10025,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,10026,0)
 ;;=E11.319^^51^587^24
 ;;^UTILITY(U,$J,358.3,10026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10026,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10026,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,10026,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,10027,0)
 ;;=E11.311^^51^587^25
 ;;^UTILITY(U,$J,358.3,10027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10027,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10027,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,10027,2)
 ;;=^5002632
 ;;^UTILITY(U,$J,358.3,10028,0)
 ;;=E10.9^^51^587^13
 ;;^UTILITY(U,$J,358.3,10028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10028,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,10028,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,10028,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,10029,0)
 ;;=E10.311^^51^587^11
 ;;^UTILITY(U,$J,358.3,10029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10029,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10029,1,4,0)
 ;;=4^E10.311
 ;;^UTILITY(U,$J,358.3,10029,2)
 ;;=^5002592
 ;;^UTILITY(U,$J,358.3,10030,0)
 ;;=E10.319^^51^587^12
 ;;^UTILITY(U,$J,358.3,10030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10030,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10030,1,4,0)
 ;;=4^E10.319
 ;;^UTILITY(U,$J,358.3,10030,2)
 ;;=^5002593
 ;;^UTILITY(U,$J,358.3,10031,0)
 ;;=E10.36^^51^587^1
 ;;^UTILITY(U,$J,358.3,10031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10031,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Cataract
 ;;^UTILITY(U,$J,358.3,10031,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,10031,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,10032,0)
 ;;=E10.39^^51^587^2
 ;;^UTILITY(U,$J,358.3,10032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10032,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complication
 ;;^UTILITY(U,$J,358.3,10032,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,10032,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,10033,0)
 ;;=E10.321^^51^587^3
 ;;^UTILITY(U,$J,358.3,10033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10033,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10033,1,4,0)
 ;;=4^E10.321
 ;;^UTILITY(U,$J,358.3,10033,2)
 ;;=^5002594
 ;;^UTILITY(U,$J,358.3,10034,0)
 ;;=E10.329^^51^587^4
 ;;^UTILITY(U,$J,358.3,10034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10034,1,3,0)
 ;;=3^DM Type 1 w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10034,1,4,0)
 ;;=4^E10.329
 ;;^UTILITY(U,$J,358.3,10034,2)
 ;;=^5002595
 ;;^UTILITY(U,$J,358.3,10035,0)
 ;;=E10.331^^51^587^5
 ;;^UTILITY(U,$J,358.3,10035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10035,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10035,1,4,0)
 ;;=4^E10.331
 ;;^UTILITY(U,$J,358.3,10035,2)
 ;;=^5002596
 ;;^UTILITY(U,$J,358.3,10036,0)
 ;;=E10.339^^51^587^6
 ;;^UTILITY(U,$J,358.3,10036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10036,1,3,0)
 ;;=3^DM Type 1 w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10036,1,4,0)
 ;;=4^E10.339
 ;;^UTILITY(U,$J,358.3,10036,2)
 ;;=^5002597
 ;;^UTILITY(U,$J,358.3,10037,0)
 ;;=E10.341^^51^587^9
 ;;^UTILITY(U,$J,358.3,10037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10037,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10037,1,4,0)
 ;;=4^E10.341
 ;;^UTILITY(U,$J,358.3,10037,2)
 ;;=^5002598
 ;;^UTILITY(U,$J,358.3,10038,0)
 ;;=E10.349^^51^587^10
 ;;^UTILITY(U,$J,358.3,10038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10038,1,3,0)
 ;;=3^DM Type 1 w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10038,1,4,0)
 ;;=4^E10.349
 ;;^UTILITY(U,$J,358.3,10038,2)
 ;;=^5002599
 ;;^UTILITY(U,$J,358.3,10039,0)
 ;;=E10.351^^51^587^7
 ;;^UTILITY(U,$J,358.3,10039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10039,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,10039,1,4,0)
 ;;=4^E10.351
 ;;^UTILITY(U,$J,358.3,10039,2)
 ;;=^5002600
 ;;^UTILITY(U,$J,358.3,10040,0)
 ;;=E10.359^^51^587^8
 ;;^UTILITY(U,$J,358.3,10040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10040,1,3,0)
 ;;=3^DM Type 1 w/ Prolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,10040,1,4,0)
 ;;=4^E10.359
 ;;^UTILITY(U,$J,358.3,10040,2)
 ;;=^5002601
 ;;^UTILITY(U,$J,358.3,10041,0)
 ;;=E08.311^^51^587^39
 ;;^UTILITY(U,$J,358.3,10041,1,0)
 ;;=^358.31IA^4^2
